CClinicalTrials.gg
CompletedNCT00155337Updated Dec 21, 2012

Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia

A Phase 4 interventional study of photodynamic therapy in Oral Leukoplakia, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2012-12-21.

Sponsored by National Taiwan University Hospital · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 80 Years
Sex
All
01

Study summary

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Read the detailed description

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

02

Conditions studied

  • Oral Leukoplakia

Keywords

  • leukoplakia
  • erythroleukoplakia
  • photodynamic therapy
03

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients with leukoplakia or erythroleukoplakia

Exclusion criteria

Exclusion Criteria:

  • oral cancers
04

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Interventions

  • Procedurephotodynamic therapy
05

What researchers measure

Primary outcomes

  1. End of 8 treatments

Secondary outcomes

  1. Regression of lesions

06

Study locations

1 site
  • National Taiwan University Hospital
    Taipei, 100, Taiwan
07

Registry details

Key details

Study ID
NCT00155337
Lead sponsor
National Taiwan University Hospital
First posted
Sep 12, 2005
Start date
Aug 2004
Primary completion
Dec 2007
Completion
Dec 2007
Last update
Dec 21, 2012

Study contacts

Chun-Pin Chiang, DMSc
principal investigator · National Taiwan University Hospital
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion